Equine sarcoids are the most common skin tumors in horses. Treatment decisions require balancing welfare of the horse against treatment side effects and recurrence risk.
Equine sarcoid treatment decisions require genuine welfare assessment rather than reflexive treatment of all tumors. Some sarcoids in non-functional locations remain stable for years and treatment side effects may outweigh the welfare benefit of removing them. Others in functionally critical locations including periocular and girth areas cause significant pain and functional impairment requiring proactive treatment. The welfare standard requires individual assessment of each sarcoid including location, growth rate, functional impact, and treatment side effect profile to make a decision that genuinely serves the individual horse's interests rather than owner anxiety or cosmetic concerns.